Search research articles
Contact Us
Filters
Showing results (61-70 of 228) with videos related to
Page
of 23
Sort By:
Drug and Alcohol Dependence
|
June 14, 2002
GHB use among Australians: characteristics, use patterns and associated harm
Louisa Degenhardt, Shane Darke, Paul Dillon
Addiction (Abingdon, England)
|
August 17, 2006
Systemic disease among cases of fatal opioid toxicity
Shane Darke, Sharlene Kaye, Johan Duflou
Addiction (Abingdon, England)
|
October 10, 2024
Rare but relevant series
Shane Darke, Michael Farrell, Julia Lappin
Journal of Forensic Sciences
|
March 3, 2011
Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999-2008
Shane Darke, Johan Duflou, Michelle Torok
Drug and Alcohol Dependence
|
January 25, 2005
Cocaine-related fatalities in New South Wales, Australia 1993-2002
Shane Darke, Sharlene Kaye, Johan Duflou
Forensic Science International
|
February 19, 2010
A reduction in blood morphine concentrations amongst heroin overdose fatalities associated with a sustained reduction in street heroin purity
Shane Darke, Johan Duflou, Michelle Torok
Addiction (Abingdon, England)
|
November 7, 2017
Methamphetamine-related death is an under-addressed public health problem
Shane Darke, Sharlene Kaye, Johan Duflou
Drug and Alcohol Review
|
March 17, 2007
The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence?
Shane Darke, Joanne Ross, Maree Teesson
Addiction (Abingdon, England)
|
December 13, 2006
Comparative cardiac pathology among deaths due to cocaine toxicity, opioid toxicity and non-drug-related causes
Shane Darke, Sharlene Kaye, Johan Duflou
Addiction (Abingdon, England)
|
January 5, 2024
Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders?
Wayne Hall, Shane Darke, Michael Farrell
Page
of 23
Search research articles
Search
Showing results (61-70 of 228) with videos related to
Sort By:
Page
of 23
Drug and Alcohol Dependence
|
June 14, 2002
GHB use among Australians: characteristics, use patterns and associated harm
Louisa Degenhardt, Shane Darke, Paul Dillon
Addiction (Abingdon, England)
|
August 17, 2006
Systemic disease among cases of fatal opioid toxicity
Shane Darke, Sharlene Kaye, Johan Duflou
Addiction (Abingdon, England)
|
October 10, 2024
Rare but relevant series
Shane Darke, Michael Farrell, Julia Lappin
Journal of Forensic Sciences
|
March 3, 2011
Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999-2008
Shane Darke, Johan Duflou, Michelle Torok
Drug and Alcohol Dependence
|
January 25, 2005
Cocaine-related fatalities in New South Wales, Australia 1993-2002
Shane Darke, Sharlene Kaye, Johan Duflou
Forensic Science International
|
February 19, 2010
A reduction in blood morphine concentrations amongst heroin overdose fatalities associated with a sustained reduction in street heroin purity
Shane Darke, Johan Duflou, Michelle Torok
Addiction (Abingdon, England)
|
November 7, 2017
Methamphetamine-related death is an under-addressed public health problem
Shane Darke, Sharlene Kaye, Johan Duflou
Drug and Alcohol Review
|
March 17, 2007
The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence?
Shane Darke, Joanne Ross, Maree Teesson
Addiction (Abingdon, England)
|
December 13, 2006
Comparative cardiac pathology among deaths due to cocaine toxicity, opioid toxicity and non-drug-related causes
Shane Darke, Sharlene Kaye, Johan Duflou
Addiction (Abingdon, England)
|
January 5, 2024
Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders?
Wayne Hall, Shane Darke, Michael Farrell
Page
of 23